Clinical trial on effectiveness of favipiravir starts

TEHRAN ( Iran News ) – Iranian medical authorities have agreed on carrying out a clinical trial on the effectiveness of favipiravir, a drug originally used in Japan for the treatment of new types of influenza. Shahid Beheshti University of Medical Sciences has announced that a clinical trial began by Tehran’s Masih Daneshvari hospital on Sunday aimed at determining favipiravir’s effectiveness in treating patients infected with COVID-19